Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: Cancer Res. 2015 Dec 30;76(6):1560–1568. doi: 10.1158/0008-5472.CAN-15-2401

Table 1.

Summary of enhancement of RG7787 activity by combination with DDR1 siRNA or with DDR1 Inhibitor 7rh in MSLN-expressing cell lines

Cell line Control si + RG7787 IC50 (ng/ml) DDR1 siRNA + RG7787 IC50 (ng/ml) RG7787 alone IC50 (ng/ml) 7rh + RG7787 IC50 (ng/ml)
KB 40 2 >100 6
A431/H9 11 1.5 2 0.1
HAY 11 1.5 35 5
KLM1 8 3.7 11 2
ASPC1 40 0.7 -- --
L55S -- -- 10 3
SUM149 -- -- 11 1
HCC70 -- -- 4 0.4